Metastatic GCTs can further be subdivided in terms of their risk of relapse into favourable, intermediate and poor risk; according to the combination of tumour size, histology, distribution of disease and the level of the tumour markers; alfa feto-protein (AFP; human chorionic gonadotrophin hormone (HCG); and lactate dehydrogenase (LDH). Here, AFP is linked to neoplasm.